Adder bites - Clinical picture, diagnosis and management;Kreuzotterbisse - Klinik, diagnostik und behandlung

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 20, 2008, Pages 1075-1080

  Prenzel, Freerk ^a   Schulz, M ^a   Siekmeyer, W ^a   Rahn, W ^b   Kiess, W ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Ev Diakonissenkrankenhaus Leipzig gGmbH

Author keywords

Adder bite; Anaphylaxis; Antivenom treatment; Vipera berus

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BRADYKININ; CORTICOSTEROID; HEPARIN; HISTAMINE; PROSTAGLANDIN; SEROTONIN; SNAKE VENOM ANTISERUM; VIPERA TAB; VIPERFAV; VENOM ANTISERUM; VIPER VENOM;

ALLERGIC REACTION; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SNAKEBITE; TREATMENT INDICATION; AGE DISTRIBUTION; AGED; ANIMAL; CHILD; GERMANY; IMMUNOLOGY; SNAKE;

AGE DISTRIBUTION; AGED; ANIMALS; ANTIVENINS; CHILD; GERMANY; HUMANS; SNAKE BITES; VIPER VENOMS; VIPERIDAE;

EID: 43249091684     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1077221     Document Type: Review

References (32)

1. Audebert F, Sorkine M, Bon C. Envenoming by viper bites in France: clinical gradation and biological quantification by ELISA. Toxicon 1992; 30: 599-609
2. Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust 2006; 185: 283-289
3. Calderon L, Lomonte B, Gutierrez JM et al. Biological and biochemical activities of Vipera berus (European viper) venom. Toxicon 1993; 31: 743-753
4. Cawrse NH, Inglefield CJ, Hayes C et al. A snake in the clinical grass: late compartment syndrome in a child bitten by an adder. Br J Plast Surg 2002; 55: 434-435
5. Cederholm I, Lennmarken C. Vipera berus bites in children - experience of early antivenom treatment. Acta Paediatr Scand 1987; 76: 682-684
6. Frangides C, Kouni S, Niarchos C et al. Hypersersensitivity and Kounis syndrome due to a viper bite. Eur J Intern Med 2006; 17: 215-216
7. Gronlund J, Vuori A, Nieminen S. Adder bites. A report of 68 cases. Scand J Surg 2003; 92: 171-174
8. Harry P, de Haro L, Asfar P et al. Evaluation of intravenous immunotherapy with purified F(ab′)2 fragments (Viperfav). Presse Med 1999; 28: 1929-34
9. Hoffmann RW. Giftschlangen Europas. Tierärztl Prax Ausg K Kleintiere Heimtiere 1998; 26: 89-94
10. Johnston MA, Tullett WM. Adder (Vipera berus) bites: a case report and review of the management for emergency medical personnel. Arch Emerg Med 1993; 10: 375-9
11. Kalkum M. Bissverletzungen durch Kreuzottern. Notfall & Rettungsmedizin 1998; 1: 150-155
12. Karlson-Stiber C, Persson H. Antivenom treatment in Vipera berus envenoming - report of 30 cases. J Intern Med 1994; 235: 57-61
13. Karlson-Stiber C, Persson H, Heath A et al. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J Intern Med 1997; 241: 53-58
14. Karlson-Stiber C, Salmonson H, Persson H. A nationwide study of Vipera berus bites during one year-epidemiology and morbidity of 231 cases. Clin Toxicol (Phila) 2006; 44: 25-30
15. Kleber JJ, Zilker T. Kreuzotterbisse beim Menschen. Tierärztl Prax Ausg K Kleintiere Heimtiere 1998; 26: 95-100
16. Lomonte B, Leon G, Hanson LA. Similar effectiveness of Fab and F(ab′)2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice. Toxicon 1996; 34: 1197-1202
17. Märtson M, Taittonen M, Alanen M, Reunanen M. Vipera berus adder bite in the water, complicated by rapid shock. A case history. Eur J Pediatr Surg 2001; 11: 358-360
18. Mebs D. Gifttiere. 2nd ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2000
19. Meier J, Rauber-Lüthy C, Kupferschmidt H. Aspisviper und Kreuzotter: die medizinisch bedeutsamen Giftschlangen der Schweiz. Schweiz Med Forum 2003; 34: 780-785
20. Nedospasov AA, Rodina EV. Age changes of Vipera berus venom amidolytic activity. Toxicon 1992; 30: 1505-1508
21. Persson H, Irestedt B. A study of 136 cases of adder bite treated in Swedish hospitals during one year. Acta Med Scand 1981; 210: 433-439
22. Reading CJ. Incidence, pathology, and treatment of adder (Vipera berus L.) bites in man. J Accid Emerg Med 1996; 13: 346-351
23. Reimers AR, Weber M, Muller UR. Are anaphylactic reactions to snake bites immunoglobulin E-mediated? Clin Exp Allergy 2000; 30: 276-282
24. Ring J, Brockow K, Duda D et al. Akuttherapie anaphylaktischer Reaktionen. Allergo J 2007; 16: 420-434
25. Sampson HA, Muñoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397
26. Schiemenz H. Die Kreuzotter (Vipera berus). 4 ed. Hohenwarsleben: Westarp Wissenschaften, 2004
27. Schmutz J, Stahel E. Anaphylactoid reactions to snakebite. Lancet 1985; 2: 1306-
28. Sjostrom L, Karlson-Stiber C, Persson H, Al-Abdulla IH, Smith DC. Development and clinical application of immunoassays for European adder (Vipera berus berus) venom and antivenom. Toxicon 1996; 34: 91-98
29. Stahel E, Wellauer R, Freyvogel TA. [Poisoning by domestic vipers (Vipera berus and Vipera aspis). A retrospective study of 113 patients). Schweiz Med Wochenschr 1985; 115: 890-896
30. http://www.giftberatung.de, Vergiftungs- Informations- Zentrale Freiburg, Jahresberichte (3.3.2008)
31. http://www.bbges.de, Institut für Toxikologie, Giftnotruf Berlin, Jahresberichte (3.3.2008)
32. http://www.toxinfo.org. Toxikologische Abteilung und Giftnotruf II. Med. Klinik der Technischen Universität München, Munich Antivenom Index (MAVIN) http://www.toxinfo.org/frameset.php?class=23&hauptframe=/antivenoms/ index.html (3.3.2008)